Document is current
Any future updates will be listed below
-
Authors
Seifert, Anna M.
Richter, Sven
Sagerer, André
Lemnian, Ioana
Herold, Sylvia
Brückmann, Sascha
Emmanouilidis, Dimitrios
Alkhatib, Majd
Eyüpoglu, Ilker Y.
Williams, Erik A.
Cahill, Daniel P.
Juratli, Tareq A.
-
Funding
Funding for this research was provided by:
Technische Universität Dresden
- License Information
-
More Information
Article History
Received: 15 April 2026
Accepted: 16 May 2026
First Online: 10 June 2026
Declarations
:
: This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Ethics Committee at the Technical University of Dresden, Germany (EK 323122008).
: Written informed consent was obtained from all patients.
: Not applicable.
: TAJ has consulted for CSL Behring and Stryker (2025), serves on the Scientific Advisory Board for IPSEN (2026). DPC has received financial compensation from Boston Scientific (2025), Servier (2023), GlaxoSmithKline (2021), Lilly (2020), and Boston Pharmaceuticals (2020) for advisory input. He has also received financial compensation and travel reimbursement from Merck for invited lectures (2016), and from the US NIH and DOD for clinical trial and grant review (2024).
